SI1713830T1 - Anti-EpCAM imunoglobulin - Google Patents

Anti-EpCAM imunoglobulin

Info

Publication number
SI1713830T1
SI1713830T1 SI200530759T SI200530759T SI1713830T1 SI 1713830 T1 SI1713830 T1 SI 1713830T1 SI 200530759 T SI200530759 T SI 200530759T SI 200530759 T SI200530759 T SI 200530759T SI 1713830 T1 SI1713830 T1 SI 1713830T1
Authority
SI
Slovenia
Prior art keywords
immunoglobulin
human
administering
frequently
once
Prior art date
Application number
SI200530759T
Other languages
English (en)
Inventor
Malte Peters
Mathias Locher
Nadja Prang
Cornelia Quadt
Original Assignee
Micromet Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Micromet Ag filed Critical Micromet Ag
Publication of SI1713830T1 publication Critical patent/SI1713830T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
SI200530759T 2004-02-13 2005-02-09 Anti-EpCAM imunoglobulin SI1713830T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/778,915 US20050180979A1 (en) 2004-02-13 2004-02-13 Anti-EpCAM immunoglobulins
PCT/EP2005/001307 WO2005080428A2 (en) 2004-02-13 2005-02-09 Anti-epcam immunoglobulins
EP05707293A EP1713830B1 (en) 2004-02-13 2005-02-09 Anti-epcam immunoglobulins

Publications (1)

Publication Number Publication Date
SI1713830T1 true SI1713830T1 (sl) 2009-10-31

Family

ID=34838270

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200530759T SI1713830T1 (sl) 2004-02-13 2005-02-09 Anti-EpCAM imunoglobulin

Country Status (24)

Country Link
US (3) US20050180979A1 (sl)
EP (2) EP1713830B1 (sl)
JP (1) JP5220315B2 (sl)
KR (1) KR101236224B1 (sl)
CN (1) CN1976951B (sl)
AT (1) ATE437186T1 (sl)
AU (1) AU2005215874B2 (sl)
BR (1) BRPI0507660A (sl)
CA (1) CA2555694C (sl)
DE (1) DE602005015544D1 (sl)
DK (1) DK1713830T3 (sl)
EA (1) EA011951B1 (sl)
ES (1) ES2328159T3 (sl)
HK (1) HK1096103A1 (sl)
IL (1) IL177069A (sl)
MX (1) MXPA06008942A (sl)
NO (1) NO339364B1 (sl)
NZ (1) NZ549125A (sl)
PL (1) PL1713830T3 (sl)
PT (1) PT1713830E (sl)
SI (1) SI1713830T1 (sl)
UA (1) UA87128C2 (sl)
WO (1) WO2005080428A2 (sl)
ZA (1) ZA200606083B (sl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3351919A1 (en) 2003-01-24 2018-07-25 University of Utah Methods of predicting mortality risk by determining telomere length
US7976842B2 (en) 2006-02-09 2011-07-12 Micromet Ag Treatment of metastatic breast cancer
EP1865001A1 (en) * 2006-06-08 2007-12-12 Gsf-Forschungszentrum Für Umwelt Und Gesundheit, Gmbh Specific protease inhibitors and their use in cancer therapy
ATE509956T1 (de) * 2006-06-08 2011-06-15 Helmholtz Zentrum Muenchen Spezifische proteaseinhibitoren und ihre verwendung in der krebstherapie
PT2142570E (pt) * 2007-04-04 2011-09-13 Sigma Tau Ind Farmaceuti Anticorpos anti-epcam e suas utilizações
AU2009329987B2 (en) 2008-12-22 2016-08-04 University Of Utah Research Foundation Monochrome multiplex quantitative PCR
AU2010295172B2 (en) * 2009-09-21 2016-08-04 Ranju Ralhan Methods and compositions for the diagnosis and treatment of thyroid cancer
CN104168916B (zh) * 2012-03-02 2017-07-04 中央研究院 抗上皮细胞黏着分子(EpCAM)抗体及其使用方法
CN103387990B (zh) * 2012-09-24 2016-01-06 厦门大学 上皮细胞粘附分子的核酸适体EpCAM B及其制备方法
JP6546158B2 (ja) 2013-05-22 2019-07-17 テロメア ダイアグノスティクス インコーポレイテッド 短いテロメアの存在量の測定
CN103275226B (zh) * 2013-06-09 2017-08-29 中国科学技术大学 特异性抗人上皮细胞粘附分子（EpCAM）的单克隆抗体的制备、鉴定及应用
AU2015372584A1 (en) 2014-12-30 2017-06-29 Telomere Diagnostics, Inc. Multiplex quantitative PCR
WO2017087789A1 (en) * 2015-11-19 2017-05-26 Revitope Limited Functional antibody fragment complementation for a two-components system for redirected killing of unwanted cells
WO2018019772A1 (en) 2016-07-26 2018-02-01 Tessa Therapeutics Pte. Ltd. Chimeric antigen receptor
WO2020018964A1 (en) 2018-07-20 2020-01-23 Fred Hutchinson Cancer Research Center Compositions and methods for controlled expression of antigen-specific receptors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5853697A (en) * 1995-10-25 1998-12-29 The United States Of America, As Represented By The Department Of Health & Human Services Methods of treating established colitis using antibodies against IL-12
EP0970126B1 (en) * 1997-04-14 2001-04-18 Micromet AG Novel method for the production of antihuman antigen receptors and uses thereof
US6855544B1 (en) * 1999-04-15 2005-02-15 Crucell Holland B.V. Recombinant protein production in a human cell
US7605238B2 (en) * 1999-08-24 2009-10-20 Medarex, Inc. Human CTLA-4 antibodies and their uses
MXPA03009924A (es) * 2001-05-03 2004-01-29 Merck Patent Gmbh Anticuerpo recombinante especifico de tumor y uso del mismo.
US20030175268A1 (en) * 2002-01-11 2003-09-18 Saint-Remy Jean-Marie R. Method and pharmaceutical composition for preventing and/or treating systemic inflammatory response syndrome
WO2003099205A2 (en) * 2002-05-20 2003-12-04 Abgenix, Inc. Treatment of renal carcinoma using antibodies against the egfr

Also Published As

Publication number Publication date
CA2555694C (en) 2013-04-16
JP5220315B2 (ja) 2013-06-26
AU2005215874A1 (en) 2005-09-01
US20070274982A1 (en) 2007-11-29
NO339364B1 (no) 2016-12-05
HK1096103A1 (en) 2007-05-25
PT1713830E (pt) 2009-10-19
EA200601386A1 (ru) 2007-06-29
WO2005080428A2 (en) 2005-09-01
IL177069A0 (en) 2006-12-10
BRPI0507660A (pt) 2007-07-17
ZA200606083B (en) 2007-10-31
KR101236224B1 (ko) 2013-02-22
PL1713830T3 (pl) 2010-01-29
EP1713830A2 (en) 2006-10-25
CN1976951B (zh) 2012-03-14
EP2107071A2 (en) 2009-10-07
NZ549125A (en) 2008-09-26
US20120294873A1 (en) 2012-11-22
EP2107071A3 (en) 2009-12-30
NO20064136L (no) 2006-11-07
IL177069A (en) 2010-11-30
UA87128C2 (ru) 2009-06-25
US20050180979A1 (en) 2005-08-18
CA2555694A1 (en) 2005-09-01
AU2005215874B2 (en) 2011-01-27
ATE437186T1 (de) 2009-08-15
DK1713830T3 (da) 2009-10-12
CN1976951A (zh) 2007-06-06
MXPA06008942A (es) 2007-01-26
WO2005080428A3 (en) 2005-11-10
EP1713830B1 (en) 2009-07-22
EA011951B1 (ru) 2009-06-30
DE602005015544D1 (de) 2009-09-03
ES2328159T3 (es) 2009-11-10
KR20070009988A (ko) 2007-01-19
JP2008500277A (ja) 2008-01-10

Similar Documents

Publication Publication Date Title
HK1096103A1 (en) Anti-epcam immunoglobulins
HK1094167A1 (en) Monoclonal antibodies to hepatocyte growth factor
MXPA06003788A (es) Anticuerpos completamente humanos contra 4-1bb humano (cd137).
DK1684869T3 (da) Fremgangsmåde til terapi af B-celle-relaterede cancersygdomme
ZA200508389B (en) Humanized antibodies to interferon alpha receptor-1(IFNAR-1)
PL401886A1 (pl) Neutralizujace o wysokim powinowactwie izolowane ludzkie przeciwcialo anty-TNF-alfa, zastosowanie tego przeciwciala, krysztal zawierajacy ludzkie przeciwcialo anty-TNF-alfa i preparat zawierajacy ten krysztal
WO2003076585A3 (en) Controlled modulation of amino acid side chain length of peptide antigens
EA200970262A1 (ru) Композиции и способы, относящиеся к антителам к глюкагоновым рецепторам
UA87093C2 (ru) ГУМАНИЗИРОВАННЫЙ ИММУНОГЛОБУЛИН, КОТОРЫЙ СПЕЦИФИЧЕСКИ СВЯЗЫВАЕТСЯ С БЕТА-АМИЛОИДНЫМ ПЕПТИДОМ (Аβ)
HK1087018A1 (en) Peptide-based passive immunization therapy for treatment of atherosclerosis
TW200517124A (en) Fully human antibodies against human 4-1BB
DK1411962T3 (da) Terapi for pancreacancer med monoklonalt stof
DK1684770T3 (da) Oligo-beta-(1, 3) -glucan og monoklonale antistoffer mod kræft
WO2003097082A3 (en) Treatment of crohn's disease or psoriasis using anti-inteferon gamma antibodies
SG156658A1 (en) Treatment of diseases
WO2005000406A3 (en) Treatment of amyloid- and epileptogenesis-associated diseases